title: Autoantibodies in hepatitis C:  red flag or bystander effect?
authors: Liver Diseases Branch, Division of Intramural Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
authors: Michele M
authors: MM
authors: Tana
authors: Theo
authors: T
authors: Heller
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000139:chemically induced*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D008297:Male; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D001323:Autoantibodies; D012254:Ribavirin